Ukrainian government sells T-shirts with viral Zelensky quote from disastrous Trump meeting How close is Alex Ovechkin to breaking Wayne Gretzky's NHL career goals record? White House announces 30 ...

Those individuals who have “been there and got the T-shirt” are all too rare in the ... such as the Stevenage Bioscience Catalyst on the GSK site facilitate these kinds of interactions and ...

Nottingham Forest and Leicester City - warning them of the risks associated with promoting illegal gambling websites on their shirts. Britain's L&G sells US protection unit to Japanese insurer for ...

The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

Now, GSK is ready to play catch-up after nabbing its own FDA approval. The FDA approved the British drugmaker's Penmenvy vaccine to protect people ages 10 to 25 against meningococcal serogroups A ...

Read Our Latest Report on GSK GSK Stock Up 0.9 % Shares of GSK stock opened at $40.41 on Tuesday. The stock has a market capitalization of $83.74 billion, a price-to-earnings ratio of 25.41, a PEG ...

GSK's revenue and EPS exceeded my expectations and those of analysts, thanks to the strong performance of its oncology and HIV franchises. So, Ojjaara/Omjjara sales amounted to $150 million in the ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the ...

CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 ...